Zymomonas mobilis is a potentially useful organism for commercial biological ethanol production (2, 11, 14, 15) . This bacterium performs consistently well in fermentation trials up to and including pilot plant scale (5, 13, 16, 18; Anonymous, Bio-hol: a Progress Report, Bio-hol Developments, Toronto, Ontario, Canada, 1983).
Earlier literature reports by Gongalves de Lima and co-workers have suggested a possible role for Z. mobilis as a therapeutic agent (9, 10 ; for review, see reference 24). They described the ability of Z. mobilis to antagonize the growth of a wide variety of bacteria and fungi. The effects of inhibition by Z. mobilis are particularly evident during attempts to transfer functions from more catabolically diverse organisms, such as Escherichia coli and Pseudomonas aeruginosa, into Z. mobilis by conjugation (19, 22, 23 (19) . The factor(s) responsible is a low-molecular-weight, agar-diffusible, heat-and protease-resistant, broad-spectrum activity which is produced by all strains tested (19 To prepare cells for treatment with NTG, an overnight culture of GK646 was diluted 1:1 with fresh YG medium, dispensed in 1-ml aliquots into sterile 1.5-ml Eppendorf microcentrifuge tubes, and incubated for an additional 2 h. Cells were harvested by centrifugation (10 s at 10,000 x g; Beckman microcentrifuge B), washed with 1 ml of phosphate-buffered saline (8.5 g of NaCl, 0.3 g of KH2PO4 and 0.6 g of Na2HPO4 per liter), and resuspended in 1 ml of YG medium supplemented with NTG (100 ,ug/ml). Cells were exposed to the NTG for 2 h (0.01% survival) before being washed and resuspended in 1 Colonies formed by cells which had survived NTG treatment showed considerable heterogeneity in size, ranging from <1 to 3 mm in diameter. Although we have observed small colonies on GK646 control plates, the variation in colony size was greatly increased by NTG treatment. About 10% of the 222 colonies screened after NTG treatment showed drastically reduced halo sizes relative to untreated controls. Standardized screening of surviving colonies showed halo sizes ranging from slight peripheral clearing to 2.5 cm in diameter for the GK646 control spots. Two strains (designated GK648 and GK649) had no halos after repeated testing (Fig. 1) . These putative mutants grew more slowly than the GK646 parent but otherwise showed typical Z. mobilis glucose fermentation, colony and cellular morphology, and gram-negative staining characteristics.
We found no spontaneous wild-type revertant colonies on plates of GK648 (over 1,000 colonies screened) or GK649 (over 2,000 colonies screened). No spontaneously arising Zin-strains were found among untreated GK646 colonies (over 500 colonies screened). It is noteworthy that treatment of strain GK646 with mitomycin C (25 p.g/ml, 37°C, 48 h) or acridine orange (100 V.g/ml, 37°C, 48 h) has so far failed to generate Zin-strains (over 500 colonies screened).
Although the underlying genetic basis is unknown, the isolation of Zin-strains is the first step in the genetic analysis of growth inhibition caused by Z. mobilis. These mutants and additional isolates could be used for the identification of structural and regulatory lesions, and we are hopeful that they will shed further light on the genetic and physiological nature of this intergeneric antagonism. Inhibition is the only genetic marker currently available for Zymomonas strains aside from antibiotic resistance and auxotrophy. Should it prove to be coded by a single gene or operon which contains unique restriction enzyme sites, it would be a good candidate for use as a genetic marker in the development of plasmid shuttle vectors. Inactivation of a plasmid-borne gene by cleavage with a restriction enzyme followed by insertion of passenger DNA is a well-established technique in current recombinant DNA technology (3) . Insertional inactivation of a gene coding for inhibition could be readily detected in Z. mobilis by the screening procedure described here.
Intergeneric inhibition may have important consequences for the' industrial application of Z. mobilis. The substrate range of known strains is restricted to glucose, fructose, and sucrose (24) . This problem has prompted the study of simultaneous saccharification-fermentation systems involving cocultures of Z. mobilis with other microorganisms (1, 7, 17) . If growth-inhibitory factors are produced during fermentation, Z. mobilis may have detrimental effects on a coculture system at the expense of productivity.
The biochemical nature of this antagonism is unknown. Primary metabolic products may be directly or indirectly responsible, or Z. mobilis may produce compounds similar to broad-spectrum antibiotics or bacteriocins. It is conceivable that the antagonistic factor(s) may jeopardize the proposed use of spent cells as a feed supplement (12) or present a health hazard in the handling of spent broth or the consumption of beverages fermented or contaminated by Z. mobilis.
